These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 38140103)

  • 1. Colorectal Cancer Stem Cells and Targeted Agents.
    Zhao H; Han R; Wang Z; Xian J; Bai X
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer stem cells and signalling pathways through phytochemicals: A promising approach against colorectal cancer.
    Liao W; Zhang L; Chen X; Xiang J; Zheng Q; Chen N; Zhao M; Zhang G; Xiao X; Zhou G; Zeng J; Tang J
    Phytomedicine; 2023 Jan; 108():154524. PubMed ID: 36375238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells, colorectal cancer and cancer stem cell markers correlations.
    Cherciu I; Bărbălan A; Pirici D; Mărgăritescu C; Săftoiu A
    Curr Health Sci J; 2014; 40(3):153-61. PubMed ID: 25729599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance.
    Ebrahimi N; Afshinpour M; Fakhr SS; Kalkhoran PG; Shadman-Manesh V; Adelian S; Beiranvand S; Rezaei-Tazangi F; Khorram R; Hamblin MR; Aref AR
    Crit Rev Oncol Hematol; 2023 Feb; 182():103920. PubMed ID: 36702423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.
    Zhu Q; Shen Y; Chen X; He J; Liu J; Zu X
    Onco Targets Ther; 2020; 13():525-540. PubMed ID: 32021295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.
    Silva VR; Santos LS; Dias RB; Quadros CA; Bezerra DP
    Cancer Commun (Lond); 2021 Dec; 41(12):1275-1313. PubMed ID: 34791817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication.
    Pádua D; Figueira P; Ribeiro I; Almeida R; Mesquita P
    Front Cell Dev Biol; 2020; 8():442. PubMed ID: 32626705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and molecular mechanism of stem cells in colorectal cancer initiation.
    Wang MY; Qiu YH; Cai ML; Zhang CH; Wang XW; Liu H; Chen Y; Zhao WL; Liu JB; Shao RG
    J Drug Target; 2020 Jan; 28(1):1-10. PubMed ID: 31244351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
    Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.
    Borlongan MC; Wang H
    Front Cell Dev Biol; 2023; 11():1125174. PubMed ID: 37305676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review.
    Guo S; Zheng S; Liu M; Wang G
    Pharmaceutics; 2024 Aug; 16(8):. PubMed ID: 39204369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Bioprinted GelMA-Nanoclay Hydrogels Induce Colorectal Cancer Stem Cells Through Activating Wnt/β-Catenin Signaling.
    Zhang Y; Wang Z; Hu Q; Luo H; Lu B; Gao Y; Qiao Z; Zhou Y; Fang Y; Gu J; Zhang T; Xiong Z
    Small; 2022 May; 18(18):e2200364. PubMed ID: 35229478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer stem cells-origin, characteristics and therapy.
    Prabavathy D; Swarnalatha Y; Ramadoss N
    Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
    Bhal S; Kundu CN
    Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.